KEGG DRUG: アムロジピン・バルサルタン・ヒドロクロロチアジド
ウェブC09D アンジオテンシン II 受容体遮断薬 (ARBs)、混合. C09DX アンジオテンシン II 受容体遮断薬 (ARBs)とその他の併用. C09DX01 バルサルタン、アムロジピン、ヒドロクロロチアジド. D10286 アムロジピン・バルサルタン・ヒドロクロロチアジド <US>. 医療用医薬品のUSP ...
ATCDDD - ATC/DDD Index - Anatomical Therapeutic ...
ウェブFor the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03. The DDDs are based on the treatment of mild-moderate hypertension. See comments to C02L concerning the principles for assignment of DDDs for combined ...
KEGG DRUG: Amlodipine, valsartan and hydrochlorothiazide
ウェブAnatomical Therapeutic Chemical (ATC) classification [BR: br08303] C CARDIOVASCULAR SYSTEM. C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM. C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS. C09DX Angiotensin II receptor blockers (ARBs), other combinations. C09DX01 …
KEGG BRITE: 解剖治療化学分類 (ATC分類)
ウェブC09DX01 バルサルタン、アムロジピン、ヒドロクロロチアジド C09DX02 バルサルタンとアリスキレン C09DX03 オルメサルタンメドキソミル、アムロジピン、ヒドロクロロチアジド C09DX04 バルサルタンとサクビトリル D10226 サクビトリル L 抗 ...
ATC C09DX01: Valsartan, amlodipine and hydrochlorothiazide ...
ウェブActive ingredients in C09DX01. Combination of three antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine that belongs to the calcium antagonist class and valsartan that belongs to the angiotensin II antagonist class of medicines and hydrochlorothiazide …
N-Nitrosodimethylamine-Contaminated Valsartan and the Risk ...
ウェブ2021年5月28日 · For our cohort study we used a large longitudinal sample from the AOK, a large German statutory health insurance fund. We examined the association between filled prescriptions of potentially NDMA-contaminated valsartan drug product prescription and cancer risk in comparison with non-contaminated valsartan.
Clinical outcomes of Sacubitril/Valsartan in patients with ...
ウェブ2021年10月8日 · HFrEF patients who were hospitalized due to acute HF who received sacubitril/valsartan (Anatomical Therapeutic Chemical [ATC] classification system code, C09DX04) or comparison drugs both during the hospitalization and at the date of discharge between January 1, 2016 and August 31, 2019, were identified from the …
Dafiro HCT | European Medicines Agency
ウェブProduct information. Dafiro HCT : EPAR - Product Information. English (EN) (577.56 KB - PDF) First published: 12/11/2009 Last updated: 27/09/2023. View. Other languages (24) Latest procedure affecting product information: WS/2373. 15/12/2022. This medicine’s product information is available in all official EU languages.
Copalia HCT 10 mg/160 mg/25 mg film-coated tablets ...
ウェブCopalia HCT is used to treat high blood pressure in adult patients who are already taking amlodipine, valsartan and hydrochlorothiazide and who may benefit from taking one tablet containing all three substances. Ad.
Exforge HCT | European Medicines Agency
ウェブMeeting highlights from the Committee for Medicinal Products for Human Use ( CHMP) 17-20 October 2011. 21/10/2011. European Medicines Agency concludes that benefit-risk balance of angiotensin-II-receptor antagonists remains positive. 20/10/2011. Questions and answers on the review of angiotensin-II-receptor antagonists and the …
コンテンツに移動